Mostrar el registro sencillo del ítem

dc.contributor.authorDoña, Inmaculada
dc.contributor.authorGuidolin, Lucia
dc.contributor.authorBogas Herrera, Gádor
dc.contributor.authorOlivieri, Elisa
dc.contributor.authorLabella, Marina
dc.contributor.authorSchiapolli, Michele
dc.contributor.authorSaenz de Santa María-García, Rocío
dc.contributor.authorDama, Annarita
dc.contributor.authorSalas, María
dc.contributor.authorSenna, Gianenrico
dc.contributor.authorBonadonna, Patrizia
dc.contributor.authorTorres-Jaén, María Josefa 
dc.date.accessioned2023-01-25T08:24:51Z
dc.date.available2023-01-25T08:24:51Z
dc.date.issued2022-09-06
dc.identifier.citationDoña, I, Guidolin, L, Bogas, G, et al. Resensitization in suspected penicillin allergy. Allergy. 2023; 78: 214- 224. doi: 10.1111/all.15508es_ES
dc.identifier.urihttps://hdl.handle.net/10630/25783
dc.description.abstractThe diagnosis of allergic reactions to penicillins (AR-PEN) is very complex as there is a loss of sensitization over time, which leads to negative skin tests (STs) and specific IgE in serum, and even to tolerance to the drug involved. However, STs may become positive after subsequent exposure to the culprit drug (resensitization), with the risk of inducing potentially severe reactions. The exact rate of resensitization to penicillins is unknown, ranging from 0% to 27.9% in published studies. Objectives To analyze the rate of resensitization in patients with suggestive AR-PEN by repeating STs (retest) after an initial evaluation (IE). Material and Methods Patients with suspected AR-PEN were prospectively evaluated between 2017 and 2020. They underwent STs, and a randomized group also underwent a drug provocation test (DPT) with the culprit. Only patients with negative STs and/or DPT were included. All included cases were retested by STs at 2–8 weeks. Results A total of 545 patients were included: 296 reporting immediate reactions (IRs) and 249 non-immediate reactions (NIRs). Eighty (14.7%) cases had positive results in retest (RT+): 63 (21.3%) IRs and 17 (6.8%) NIRs (p < 0.0001). The rate of RT+ was higher in anaphylaxis compared with all other reactions (45.8% vs 9.1%, p < 0.0001). The risk of RT+ was higher from the fifth week after IE (OR: 4.64, CI: 2.1–11.6; p < 0.001) and increased with the patient's age (OR: 1.02; CI: 1.01–1.04; p = 0.009). Conclusions Due to the high rate of resensitization, retest should be included in the diagnostic algorithm of IRs to penicillins after an initial negative study, especially in anaphylaxis, to avoid potentially severe reactions after subsequent prescriptions of these drugs.es_ES
dc.description.sponsorshipThe present study has been supported by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): PI18/00095, RETIC ARADYAL RD16/0006/0001). Andalusian Regional Ministry of Economy and Knowledge (grants cofunded by European Regional Development Fund (ERDF): CTS-06603); Andalusian Regional Ministry Health (grants PI-0241-2016 and PE-0172-2018). GB holds a “Juan Rodes” (JR18/00054), Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Social Fund [ESF]). ID is a Clinical Investigator (B-0001-2017), Andalusian Regional Ministry Health.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAnafilaxiaes_ES
dc.subject.otherAnaphylaxises_ES
dc.subject.otherDrug provocation testes_ES
dc.subject.otherPenicillinses_ES
dc.subject.otherResensitizationes_ES
dc.subject.otherSkin testes_ES
dc.subject.otherSpecific IgEes_ES
dc.titleResensitization in suspected penicillin allergyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.centroFacultad de Medicinaes_ES
dc.identifier.doi10.1111/all.15508
dc.rights.ccAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional